We hypothesised that MDS samples resembling AML or NBM based on the CD34+ subset composition reflect leukaemic and indolent subtypes, respectively, whereas MDS resembling neither AML nor NBM might indicate an unfavourable non-leukaemic subtype. The gene discussed is CD34; the disease is acute myeloid leukemia.